People with type 2 diabetes who take GLP-1 drugs like Ozempic might feel a little better emotionally, but the mood boost is small and doesn’t show up in every study.

20

Pro

0

Against

Evidence from Studies

Supporting (1)

20

Community contributions welcome

20

Psychiatric effects of GLP‐1 receptor agonists: A systematic review of emerging evidence

Systematic Review

Human

2026 Jan

The study looks at the same diabetes drugs mentioned in the claim and finds they may slightly improve mood, especially in people with diabetes, which matches the claim.

Contradicting (0)

0

Community contributions welcome

No contradicting evidence found

Gold Standard Evidence Needed

According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.

Source Study

Psychiatric effects of GLP‐1 receptor agonists: A systematic review of emerging evidence

Score: 20

DOI: 10.1111/dom.70198

Similar Assertions

Taking diabetes drugs called GLP-1 receptor agonists might slightly improve mood in people, whether or not they have diabetes, based on depression score changes in studies.

55

0

88%

People with Type 2 diabetes who take GLP-1 drugs like semaglutide or liraglutide might feel a little less depressed, even if that’s not why they’re taking the medicine.

55

0

88%

People with type 2 diabetes or obesity who take GLP-1 drugs like semaglutide might be less likely to develop depression or anxiety.

50

0

86%

So far, only one in three studies has found that diabetes drugs called GLP-1 agonists might help with depression, so the proof isn't strong or clear yet.

20

0

86%

Some diabetes drugs called GLP-1 agonists might help with depression symptoms, based on a few studies — but the results aren't clear-cut and more research is needed.

20

0

86%